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Abstract
Hookworm infection is a major cause of disease burden for humans. Recent studies have described hookworm-related
immunosuppression in endemic populations and animal models. A Tissue Inhibitor of Metalloproteases (Ac-TMP-1) has been
identified as one of the most abundant proteins released by the adult parasite. We investigated the effect of recombinant
Ac-TMP-1 on dendritic cell (DC) and T cell function. Splenic T cells from C57BL/6 mice injected with Ac-TMP-1 showed
reduced proliferation to restimulation with anti CD3 or bystander antigens such as OVA. Incubation of bone marrow-derived
DCs with Ac-TMP-1 decreased MHC Class I and, especially, Class II expression but increased CD86 and IL-10 expression. Co-
incubation of splenic T cells with DCs pulsed with Ac-TMP-1 induced their differentiation into CD4+ and, particularly, CD8+
CD25+Foxp3+ T cells that expressed IL-10. These cells were able to suppress proliferation of naı ¨ve and activated CD4+ T cells
by TGF-B-dependent (CD4+ suppressors) or independent (CD8+ suppressors) mechanisms. Priming of DCs with non-
hookworm antigens, such as OVA, did not result in the generation of suppressor T cells. These data indicate that Ac-TMP-1
initiates the development of a regulatory response through modifications in DC function and generation of suppressor T
cells. This is the first report to propose a role of suppressor CD8+ T cells in gastrointestinal helminthic infections.
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Introduction
The human hookworms Necator americanus and Ancylostoma
duodenale are directly transmitted nematode parasites of the small
intestine, and the main species that cause human hookworm
infection, a leading cause of iron-deficiency anemia and
malnutrition with a prevalence of 600 million cases in the tropical
developing world [1]. Though mortality is rare, the global burden
of hookworm disease is high, with an estimated 22 million
Disability-Adjusted Life Years (DALYs) lost each year [1]. These
numbers alone outrank diseases such as African trypanosomiasis,
dengue, Chagas’ disease, schistosomiasis, and leprosy [2].
For many common helminthic infections, including ascariasis,
trichuriasis, and schistosomiasis, the intensity of infection peaks
during childhood and adolescence [3]. In contrast, there appears
to be considerable variation in the age profile of hookworm
infection. Although the hookworm burden may be heavy in
children, especially those in sub-Saharan Africa [4,5], the most
commonly recognized pattern is a steady rise in the intensity of
infection during childhood, with either a peak or a plateau in
adulthood. This lack of exposure or age-related immunity
indicates that hookworms can either evade or suppress host
immune responses. Studies performed by us and others have
confirmed that hookworm infections decrease the ability of the
immune system to respond to hookworm and bystander antigens,
as evidenced by decreased lymphocyte responses in hookworm-
infected humans [6,7,8], dogs [9] and hamsters [10,11], as well as
elevated serum IL-10 and immunosuppression in patients infected
with N. americanus [12], or infected and exposed to adult parasite
extracts [13]. Chemotherapy against the parasite restores the
immune response in humans [14] and increases the immunoge-
nicity of anti-hookworm vaccines in hamsters [10,11].
Most of the pathology caused by the hookworm results from the
adult stage of the parasite [15,16]. While feeding, adult worms
release into host tissues a battery of pharmacologically and
immunologically active molecules [17]. Work by several groups
has begun to unravel the biochemical events linked to the resultant
blood loss that develops as a consequence of parasite attachment
[18]. Among the secreted antigens, a hookworm-secreted Tissue
Inhibitor of Metalloproteases (Ac-TMP-1) has been identified in A.
caninum [19] and A. ceylanicum [20] as one of the most abundant
proteins released by the adult parasite, at a rate of 40 ng/h [19].
In this report, we aimed to investigate the effect of the
recombinant protein Ac-TMP-1 on dendritic cell function (DC)
and generation of suppressor T cells. Splenic T cells from mice
treated with Ac-TMP-1 exhibited decreased lymphoproliferative
responses when restimulated ex vivo with Ac-TIMP or anti CD3.
To understand the mechanism behind this suppression of
proliferation, we incubated bone marrow-derived dendritic cells
(DCs) from C57BL/6 mice (B/6) with Ac-TMP-1, and discovered
www.plosntds.org 1 May 2009 | Volume 3 | Issue 5 | e439that DCs exposed to the hookworm antigen decreased expression
of MHC Class I and II and increased expression of CD86 and IL-
10, as well as production of TGF-B. Moreover, co-incubation of
naı ¨ve splenic T cells with DC pulsed with Ac-TMP-1 induced their
differentiation of T cells into IL-10 producing CD4+ and CD8+
CD25+Foxp3+ regulatory T cells that suppressed proliferation of
both naı ¨ve and activated CD4+ T cells. Interestingly, neutraliza-
tion of the cytokine TGF-B reduced the suppressive ability of Ac-
TMP-derived CD4+ T cell suppressors, but did not affect the
ability of the CD8+ cells to suppress proliferation. Because CD4,
but particularly CD8+ T cells are abundant in the gut (the site of
hookworm infection) we propose a novel mechanism of immuno-
suppression by a parasitic helminth.
Materials and Methods
Recombinant Ac-TMP-1
Recombinant Ac-TMP-1 was kindly provided by Dr. Bin Zhan
and Dr. Peter Hotez at The George Washington University. To
generate the recombinant protein, a cDNA encoding a putative
tissue inhibitor of metalloproteinase was cloned from an
Ancylostoma caninum adult hookworm cDNA library by immuno-
screening with anti-hookworm secretory products antiserum. The
protocol of the cloning and protein expression is described in detail
elsewhere [19].
Mice
C57BL/6 (B/6) mice were purchased from Taconic (German-
town, NY). All mice were maintained in the Baker Institute
Animal Care Facility under pathogen-free conditions. All animal
studies were approved by the Institutional Animal Care and Use
Committee at Cornell University.
In vivo treatment with Ac-TMP-1 of C57BL/6 mice
We simulated continuous exposure by injecting 50 mg Ac-TMP-
1 or ovoalbumin (OVA) to C57BL/6 mice intraperitoneally, every
2 days, for a total of 8 days. Two days after the last injection,
spleens were collected, T cells purified with enrichment columns
(R& D Systems, Minneapolis, MN), labeled with CFSE as
described [10] and restimulated with 50 mg Ac-TMP-1 or 5 mg/
ml anti CD3. Cells were harvested 5 days later. Proliferation was
assessed by loss of CFSE staining.
In vitro bone marrow-derived DC stimulation assays
Bone marrow-derived DCs were cultured in the presence of
20 ng/ml GM-CSF and collected 6–8 days after culture. DCs were
then plated in 6-well plates (10
6/well) before Ac-TMP-1 was added
to the wells. At different time points, brefeldin A (10 mg/ml) was
added for 6 h and DCs were then collected and fixed in 4%
paraformaldehyde. Prior to staining, cells were incubated with an
anti-Fcc III/II receptor and 10% normal mouse serum (NMS) in
PBS containing 0.1% BSA, 0.01% NaN3. Cells were permeabilized
and stained for the surface markers CD11c (clone 223H7), CD80
(clone 16-10A1), CD86 (clone GL1), MHC Class I (clone 28-14-8)
and MHC Class II (clone M5/114.15.2) and for the cytokines IL-
12p40/p70(cloneC17.8)and IL-10 (cloneJES5-16E3). Incubations
were carried out for 30 min on ice. Unless specified, all antibodies
werepurchased from BD Biosciences or eBioscience. The data were
collected using a FACScalibur flow cytometer and analyzed in
CELLQuest software (Becton Dickinson, San Jose, CA). For each
sample, at least 30,000 cells were analyzed.
TGF-B detection by ELISA
ELISAs for the detection of murine TGF-B were carried out
using antibodies from R&D systems (Minneapolis, MN) following
the manufacturer’s instructions.
Phenotypic and functional characterization of T cells co-
cultured with Ac-TMP-pulsed bone marrow-derived DCs
Splenocytes were purified from spleens of naive B/6 mice by
mechanical disruption. Prior to co-culture, red blood cells were
lysed for 10 minutes with cold ACK lysing buffer. T cells were
enriched using columns as above, and added to cultures containing
bone marrow-derived DCs (5 T cells: 1 DC ratio) that have been
left unstimulated or had been treated with Ac-TMP-1 (50 mg for
16 h). Forty-eight hours after initiation of the co-culture, brefeldin
A was added for 6 h; cells were then collected and fixed in 4%
paraformaldehyde. Prior to staining, cells were incubated with an
anti-Fcc III/II receptor and 10% normal mouse serum (NMS) in
PBS containing 0.1% BSA, 0.01% NaN3. Cells were permeabi-
lized with saponin and stained for the surface markers CD4, (clone
RM4-5), CD8 (clone 53-6.7), CD25 (clone PC61.5), the transcrip-
tion factor Foxp3 (FJK-16s), IFN-c (clone XMG1.2) and IL-10
(clone JES5-16E3). Incubations were carried out for 30 min on ice.
All antibodies were purchased from BD Biosciences or
eBioscience. The data were collected and analyzed by flow
cytometry as described above.
Suppression of proliferation assay
Suppressor cells (CD4+ and CD8+) used for this assay were
generated by incubation with bone marrow-derived DCs pulsed
with 50 mg Ac-TMP-1 as described above. Following priming and
seeding of DCs, they became adherent and cannot be easily
collected from the experimental well. T cell purity was determined
following collection by cytospins, Diff quick staining and
quantitation under the microscope. The percentage of T cells
collected from the wells containing DCs was .98%. Target cells
(CD4+ T cells) were isolated from the spleens of B/6 using
magnetic beads (Miltenyi, Auburn, CA) [10]. Naı ¨ve T cells were
stained with CFSE and used immediately. Activated CD4 T cells
were generated by culture with anti-CD3 (5 mg/ml) for 3 days,
when they were also labeled with CFSE. The CD4+ or CD8+
suppressor cells were treated with 0.8 mg/ml mitomycin C (Sigma-
Author Summary
Chronic infections with helminths have been suggested to
induce suppressor cells by a variety of mechanisms. The
published immunological and epidemiological data on
hookworm infection in humans and animal models
suggest that these parasites are particularly successful in
establishing chronicity and modulation. We have demon-
strated that the recombinant form of a hookworm tissue
inhibitor of metalloprotease (Ac-TMP-1) induces bone
marrow-derived DCs to downregulate MHC Class I and II
and release anti-inflammatory cytokines such as IL-10 and
TGF-B. More importantly, DCs pulsed with Ac-TMP-1
promote the development of regulatory CD4+ and,
especially, CD8+ T cells from naı ¨ve T cells, which are able
to suppress proliferation of naı ¨ve and activated splenic
CD4+ T cells; this suppression is mediated by TGF-B for
CD4+ suppressor cells, but it is independent of the
cytokine for CD8+ suppressor cells. These studies initiate
the first steps to investigate the relevance and nature of
suppressor T cells in hookworm infections and their
mechanism of suppression.
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the CFSE labeled target cells CD4+ T cells, at a 1:1 ratio. To
trigger proliferation of target cells, anti-CD3 (5 mg/ml) and IL-2
(10 U/ml) were added. Cells were harvested, and proliferation was
measured at day 5. Neutralization of IL-10 was performed
employing anti-mouse IL-10 neutralizing antibody (R&D systems)
at a concentration of 10 ng/ml. Neutralization of TGF-B was
carried out by adding anti-mouse TGF-B neutralizing antibody
(R&D systems) at a concentration of 25 mg/ml.
Statistics
Data are presented as mean6SD or SEM. Differences were
analyzed for significance Student’s unpaired, two-tailed t-test or
ANOVA using Graph Pad Prism Software (San Diego, CA). A P
value less than 0.05 was used as the threshold for significance.
Specific P values are indicated in each figure.
Results
In vivo treatment of mice with Ac-TMP-1 decreased the
ability of their splenic T cells to proliferate ex vivo
We wanted to explore the effect of Ac-TMP-1 exposure in a small
animal model. The mouse is not a permissive model of hookworm
infection, because the parasite cannot establish itself in the gut.
Thus, we simulated continuous exposure by injecting 50 mg Ac-
TMP-1 to B/6 mice intraperitoneally, every 2 days, for a total of 8
days. This regimen was substantiated by our knowledge of the
parasite and the pharmacokinetics of the intraperitoneal route. An
adult hookworm secretes 40 ng Ac-TMP-1/h [21]. Because adult
infections typically range from 10–100 worms [22], the level of Ac-
TMP-1 in the interstitial fluid/serum at any given time should be
0.4–4 mg. Drugs given intraperitoneally have a half life in serum of
30–40 h, and a recovery of 1–10% of the original concentration. By
injecting every 2 days, Ac-TMP-1 would always be at the maximum
concentration in serum (0.5–5 mg), simulating infection conditions.
As controls, we injected either PBS or the non-hookworm protein
ovoalbumin (OVA) using the same regimen. Two days after the last
injection,spleenswerecollected,T cells purified, labeled with CFSE
and restimulated ex vivo with Ac-TMP-1, OVA or anti CD3 for 5
days. Proliferation (or lack thereof) was assessed by determining the
percentage of CFSE-positive cells. Figure 1A shows that unstimu-
lated cells did not proliferate in culture (86–90% did not lose CFSE
staining). Interestingly, mice did not proliferate in response to Ac-
TMP-1 restimulation, including the mice that were primed with the
antigen in vivo. As expected, T cells from control mice that had been
injected with PBS or OVA proliferated in response to anti CD3
(only 18–25% retained CFSE staining, P=0.002). Ex vivo
proliferation to anti CD3 was decreased in mice treated with Ac-
TMP-1 when compared to PBS-injected control animals (58 vs.
18% cells positive for CFSE, P=0.002). Most strikingly, prolifer-
ation to OVA was decreased in OVA-primed mice if cells were
restimulated ex vivo in the presence of Ac-TMP-1. This experiment
was repeated 3 times and the average6SEM is shown in Figure 1B.
These data indicate that in vivo treatment of mice with Ac-TMP-1
decreases the ability of their splenic T cells to initiate lymphopro-
liferative responses to the hookworm protein, or bystander antigens.
Incubation of bone marrow-derived DCs with Ac-TMP-1
induced changes in the expression of activation markers
and cytokines
In order to elucidate the mechanism(s) of immunosuppression
by Ac-TMP-1, we turned into in vitro models of DC-T cell
interactions. To optimize in vitro conditions, bone marrow-derived
DCs from B/6 mice were obtained and cultured in RPMI or in the
presence of increasing doses (1–100 mg) Ac-TMP-1 for 16 hours,
when the cells were collected and fixed. The Mean Intensity of
Fluorescence (MFI) in CD11c+ DCs expressing the co-stimulatory
molecules CD80 and CD86, as well as MHC Class I and II was
analyzed by flow cytometry (Figure 2A). In the presence of Ac-
TMP-1, MFIs for CD80 and CD86 were slightly increased, and
the difference was statistically significant (P=0.02) for the latter
activation marker if exposed to 50 mg Ac-TMP-1. MFI values for
MHC Class I decreased (78 in unstimulated cells vs. 51 in Ac-
TMP-1-treated cells, although the difference was not statistically
significant). In contrast, MHC Class II MFI was significantly
downregulated (P=0.008) by incubation with 50 mg Ac-TMP-1.
Because this concentration was the dose at which the highest effect
was observed, we generated a time-course curve in which the level
of MHC Class II expression was detected at 1, 6, 16 and 72 h. In
this experiment, we included a non-hookworm protein as a
control, and incubated DCs with 50 mg/ml OVA. Figure 2B
shows that the expression of the surface marker was already
decreased since after 1 h incubation with the hookworm antigen
and onwards. The downregulation of expression was statistically
significant at 6 and 16 h post antigenic exposure when compared
to RPMI-treated cells. No changes were observed in OVA-primed
DCs. These results indicated that 50 mg Ac-TMP-1 was able to
induce a biological effect on DCs in a period between 6–16 h.
Intracellular staining for the cytokines IL-12p40/p70 and IL-10
was also determined in DCs stimulated with Ac-TMP-1 or OVA
for 16 h (Figure 2C). IL-12 expression was slightly increased
following antigenic stimulation, although the difference with the
RPMI-treated control was not statistically significant. In contrast,
IL-10 expression was significantly increased (P=0.001). Cytokine
data assayed by ELISA confirmed the results (not shown). Priming
with OVA did not induce a cytokine response. Finally, the levels of
the anti-inflammatory cytokine TGF-B were determined in the
DC supernatants by ELISA. The secretion of TGF-B was
increased in DC cultures incubated with Ac-TMP-1, and
unaffected by OVA. Together, these results indicate that in vitro
treatment of bone marrow DCs with Ac-TMP-1 decreased their
ability to present antigen and increased their ability to produce
anti-inflammatory cytokines such as IL-10 and TGF-B.
Co-incubation of splenic T cells with bone marrow-
derived DCs pulsed with Ac-TMP-1 induced the
generation of CD25+Foxp3+ IL-10+ suppressor T cells
For this experiment, splenic T cells were obtained from B/6
mice and co-cultured for 48 h with either unstimulated or Ac-
TMP-1-treated bone marrow-derived DCs (for 6 h with 50 mg Ac-
TMP-1). DCs alone produced negligible amounts of cytokines
(,2%, not shown). First, we determined the percentage of CD4+
and CD8+ T cells expressing the activation marker CD25 and the
transcription factor Foxp3 (expressed in regulatory T cells). Ac-
TMP-1 priming increased Foxp3 expression in CD4+ T cells (from
5% to 20%) and especially, in CD8+ T cells (from 6% to 56%)
(Figure 3), demonstrating that the hookworm antigen induced
naı ¨ve T cells to become regulatory T cells. This finding was further
confirmed by the study of cytokines. We determined the
expression of IFN-c and IL-10 in both the CD25+Foxp32
(activated, non-regulatory T cells) and CD25+Foxp3+ lymphocyte
populations (true regulatory T cells). Cytokine expression in
unstimulated controls was ,5% (not shown). Ac-TMP-1 treatment
induced CD4+ CD25+Foxp32 cells to express IFN-c (to 12%); in
contrast, IFN-c expression in CD4+CD25+ Foxp3+ cells was only
4%. The frequency of both CD8+CD25+ Foxp3+IFN-c+ and
CD8+ CD25+Foxp32IFN-c+ cells was low (5%). Both CD4+ and
Hookworm Antigens Generate Suppressor T Cells
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www.plosntds.org 4 May 2009 | Volume 3 | Issue 5 | e439CD8+ CD25+ T cells co-cultured with Ac-TMP-1 treated DCs
expressed IL-10 (8% and 9% respectively). Interestingly, Ac-TMP-
1-treated bone marrow-derived DCs induced the highest increase
in IL-10 expression in CD4+ CD25+Foxp3+ cells (to 16%) and,
most strikingly, in the CD8+CD25+Foxp3+ population (38%).
These findings show that Ac-TMP-1-treated bone marrow-derived
DCs selectively biased the differentiation of naive T cells, in
particular CD8+ T cells, toward a regulatory phenotype via
increased expression of the transcription factor Foxp3 and the
cytokine IL-10.
Ac-TMP-1-primed CD4+ and CD8+ cells suppress
proliferation of naı ¨ve and activated CD4+ T cells via TGF-
B dependent and independent mechanisms
For these experiments, target CD4+ T cells were purified from
the spleens of naı ¨ve B/6 mice. Activated CD4+ T cells were
generated by restimulation in vitro with anti-CD3 for 3 days. Both
were labeled with CFSE, and plated. The suppressor T cells were
generated by incubation of splenic naı ¨ve T cells with bone
marrow-derived DCs pulsed with Ac-TMP-1, OVA or RPMI
(unstimulated controls). Suppressor CD4+ and CD8+ T cells were
then added to the target naı ¨ve or activated CFSE-stained CD4+ T
cells. Co-cultures were then incubated with a mixture of anti
CD3/IL-2 to enhance proliferation of target T cells in the
presence or absence of neutralizing antibodies for IL-10 and TGF-
B. Negative proliferation was quantitated as % CFSE+ cells 5 days
after initiation of co-culture.
In the absence of suppressor T cells, .70% cells proliferated in
response to antiCD3/IL-2 treatment (Figure 4); the proliferation
was unaffected by cytokine neutralization. Moreover, .70% of the
naı ¨ve CD4+ T cells proliferated following co-culture with CD4+
and CD8+ T cells incubated with unstimulated DCs. Again,
neutralization of IL-10 or TGF-B did not produce any effect.
Similarly, OVA-primed T cells were unable so suppress
proliferation of splenic T cells. Ac-TMP-1 primed-CD4+ T cells
were able to suppress the proliferation of naı ¨ve CD4+ T cells (to
35%) and activated CD4+ T cells (to 25%), although the difference
was not statistically significant when compared to unstimulated
cells alone. Treatment of cultures with anti-IL-10 antibodies
Figure 2. Ac-TMP-1 treatment affects their phenotype and cytokine expression bone marrow-derived dendritic cells. A. Flow
cytometry profiles of CD80, CD86 and MHC Class I and II expression levels in CD11c+ bone marrow-derived DCs incubated for 16 hours with RPMI or
1–100 mg recombinant Ac-TMP-1. Data are expressed as average6SEM of 3 different experiments. *: Statistically significant, P=0.02. B. Flow
cytometry profiles of MHC Class II expression levels in DCs incubated at different time points with RPMI, 50 mg recombinant Ac-TMP-1 or 50 mg OVA.
Data are expressed as average6SEM of 3 different experiments. *: Statistically significant, P=0.008. C. Intracellular cytokine staining for IL-12p40/p70
and IL-10 in CD11c+ bone marrow-derived DCs unstimulated or stimulated with Ac-TMP-1 or OVA. Data are expressed as average6SEM of 4 different
experiments. *: Statistically significant, P=0.001. D. Secretion of TGF-B in supernatants of DCs primed with the antigens as in B. Data are expressed
as average6SEM of 3 different determinations. *: Statistically significant, P=0.0001.
doi:10.1371/journal.pntd.0000439.g002
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www.plosntds.org 5 May 2009 | Volume 3 | Issue 5 | e439resulted in a decrease in the ability of Ac-TMP-1 primed CD4+ T
cells to suppress proliferation (from 35 to 48% CFSE+ cells,
although the difference was not statistically significant. However,
the decrease in suppressive ability in cultures where TGF-B was
neutralized was statistically significant (P=0.05). Finally, CD8+ T
cells primed with Ac-TMP-1 were more effective in suppressing T
cell responses by significantly decreasing the ability of both naı ¨ve
and activated CD4+ T cells to divide (to 20% and 12%,
respectively). The suppressive ability of these cells was not
abolished by neutralization of either IL-10 or TGF-B. These
results demonstrate that DC priming with Ac-TMP-1, but not
other proteins, induced the generation of CD4+ and CD8+
suppressor T cells. In our system, CD8+ suppressor T cells were
more efficient in reducing proliferation of both naı ¨ve and activated
Figure 3. Ac-TMP-1 induces generation of regulatory T cells. Splenic T cells were co-cultured with bone marrow-derived DCs treated with Ac-
TMP-1 (50 mg) for 16 h at a T cell: DC ratio of 5:1. Cells were gated by CD4 or CD8. The percentage of CD25+ expression Foxp3 was first analyzed in
the CD4 (upper left) and CD8 (lower left) populations. Then, the expression of IFN-c or IL-10 in the CD25+Foxp32 or CD25+Foxp3+ populations was
determined (right) and indicated at the upper right corner of each histogram. Data shown are representative from 3 independent experiments.
doi:10.1371/journal.pntd.0000439.g003
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neutralization of either IL-10 or TGF-B, as opposed as the CD4+
suppressors, that required both cytokines, in particular TGF-B.
Discussion
Chronic infections with helminths have been suggested to
induce suppressor cells by a variety of mechanisms. The published
immunological and epidemiological data on hookworm infection
in humans and animal models suggest that these parasites are
particularly successful in establish chronicity and modulation
[1,6,7,10,11,17,23,24,25,26,27,28]. Numerous helminth-derived
proteins are though to contribute to the immunosuppression
associated with these parasites [29,30]. Tissue inhibitors of
metalloproteases themselves have proven to have immunomodu-
latory properties [31,32,33,34]. In this report, we have investigated
the effect of the hookworm tissue inhibitor of metalloproteases Ac-
TMP-1, one of the most abundant proteins released by the
parasite following establishment, on DC function and T cell
differentiation. We have demonstrated that recombinant Ac-TMP-
1 is able to induce bone marrow-derived DCs to downregulate
MHC molecules and release anti-inflammatory cytokines. More
importantly, DCs pulsed with Ac-TMP-1 promoted the develop-
ment of regulatory T cells. Remarkably, CD8+ suppressor T cells
were more abundant, more potent, and used different suppressive
mechanisms than CD4+ T cells.
It is considered that the immature developmental stages of DC
differentiation produce tolerogenic DCs which in turn induce T
cell anergy or regulatory T cells [35]. The controlled environment
of the in vitro experiments performed by us revealed that bone
marrow-derived DCs decreased their ability to present antigen (by
downregulating MHC Class I and, especially class II expression)
and increased their ability to produce the anti-inflammatory
cytokines IL-10 and TGF-B. This phenotype is consistent with the
development of tolerogenic DCs [36]. Thus, the initiation of
suppressive responses in hookworm infectious may be initiated by
an increased frequency in the tolerogenic DC population in the
sites where the antigen is released. How CD8+ suppressor T cells
generate after the first interaction with DCs is still unknown.
Whereas downregulation of MHC Class I has been implicated in
the generation of suppressor T cells by some, others have proposed
that their generation do not require MHC mechanisms, or that it
may be caused by the recognition of other ligands, such as CD40L
[37,38,39,40]. While our studies demonstrate the generation of a
suppressive population of T cells, the exact mechanism whereby
these cells arise deserves further investigation.
Studies in human populations and animal models have
suggested that adult hookworms are immunosuppressive. In fact,
our experiments in animal models have revealed that peripheral
blood or splenic cells from dogs and hamsters infected with the
parasite do not proliferate in response to adult hookworm extracts
[9,11]. Recently, the analysis of human responses to adult
hookworm extracts demonstrate that restimulation of peripheral
blood cells with adult proteins causes an increase in IL-10
production [13]. The in vivo studies presented here support this
hypothesis and demonstrate that priming mice with the abundant
adult extract protein Ac-TMP-1 results in a decrease their
lymphoproliferative responses to TCR stimulation. More impor-
tantly, they also revealed that exposure to Ac-TMP-1 also
diminished specific proliferation to bystander antigens, such as
OVA, suggesting that the hookworm antigen is able to cause
potent, generalized immunosuppression. This is further demon-
strated by the fact that mice exposed to Ac-TMP-1 are unable to
initiate lymphoproliferative responses to the antigen. Interestingly,
Figure 4. Ac-TMP-1-induced suppressor cells decrease proliferation of CD4+ T cells. Percentage of CFSE+ cells in naı ¨ve and activated CD4+
T cell cultures following co-culture with suppressor T cells. Suppressor CD4+ or CD8+ T cells were generated through incubation with unstimulated or
either OVA or Ac-TMP-1-primed bone marrow-derived DCs. Suppressor T cells were co-incubated with CFSE-labeled naı ¨ve or anti CD3 activated CD4+
T cells and restimulated with anti CD3 and IL-2. In some wells, neutralizing antibodies against either IL-10 or TGF-B were added. The percentage of
CFSE+ cells was determined in the target population by flow cytometry. Figure shows are the mean6SD from 3 independent determinations. *:
Statistically significant, P=0.05.
doi:10.1371/journal.pntd.0000439.g004
Hookworm Antigens Generate Suppressor T Cells
www.plosntds.org 7 May 2009 | Volume 3 | Issue 5 | e439dogs vaccinated against Ac-TMP-1 did not develop proliferative
responses against the hookworm antigen (unpublished).
Our in vitro experiments attempt to begin to unravel the
underlying mechanism of immunosuppression and revealed that
priming DCs with Ac-TMP-1 induced the de novo generation of
CD4+, and more importantly, CD8+ Foxp3+ IL-10+ cells. Both
cell populations are able to display suppressive functions when co-
cultured with both CD4+ naı ¨ve and activated T cells. Interest-
ingly, the mechanism of suppression by CD4+ suppressor T cells
seems to be mediated by the release of anti-inflammatory
cytokines, whereas CD8+ suppressor T cells do not require the
presence of IL-10 or TGF-B to suppress T cell proliferation,
suggesting perhaps direct cell contact mechanisms. The existence
of suppressor CD8 populations has been documented in different
models [41,42], although their role and mechanism of suppression
remains poorly characterized. Whereas some authors postulate
that their suppressive function is dependent on IL-10 production,
some others demonstrate that their function is cytokine indepen-
dent (i.e. [38,39]). Although our data support the latter hypothesis,
further experiments need to be performed to determine the
mechanism of immunosuppression in Ac-TMP-1-primed suppres-
sor T cells, and the relevance of such mechanism in infection
models. Because the role of CD8+ suppressor T cells has been
postulated as a very important homeostatic mechanism in the gut
mucosa [43], the infection site for hookworms, the demonstration
of the role of CD8+ suppressor T cells in the regulation of gut
immunity will be of importance not only to bring forward the role
of these cells in the mucosal environment, but also to enhance the
relevance of this effector population in the context of gastrointes-
tinal parasitic infections. CD8 suppressor T cells have been
generated in vitro in response to other extracellular nematodes such
as Echinococcus multilocularis protoscoleces [44], but this is the first
report in which they have been implicated in the immune response
against gastrointestinal nematodes.
In summary, our data demonstrates that Ac-TMP-1 modulates
the immune response of the host by more than one mechanism(s).
This hookworm molecule appears to induce de-activation of the
DC and enhance IL-10 production, and to elicit the development
of T cells with regulatory functions. These findings open the door
to future studies to determine the nature of the interaction of the
hookworm antigen with antigen presenting cells, as well as to
investigate the relevance of suppressor T cells in helminthic
infections, and their mechanism of suppression.
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